About Us

Genevention is a bioinformatics company that brings together long-standing experience in semantic integration of biomedical big data, cutting-edge deep data analyses and sharp visualizations for interactive data exploration. Our aim is to combine these technologies to allow biomedical researchers, pharmaceutical engineers and bioinformaticians to discover disease-specific biomarkers, reveal novel correlations in datasets across different experiment types and easily enrich experimental data with information from the literature and external databases. Our services include the custom-tailored development of semantic data integration systems, the provision of expert-curated biomarker knowledge bases based on high-throughput-omics data and the investigation of biomedical big data using artificial intelligence approaches.

Dr. Inge Sillaber

CEO

Inge is a neurobiologist with many years of management experience in biotech industry. She has a comprehensive background in preclinical and clinical drug development.

Dr Inge Silaber
Dr. Inge SillaberCEO

Dr.Thomas Lingner

Co-founder/CSO

Thomas is a data scientist with a strong background in computational biology. His expertise covers data mining & machine learning, high-throughput sequence analysis and metagenomics.

Dr Thomas Lingner
Dr.Thomas LingnerCo-founder / CSO

Prof. Dr. Stefan Bonn

Co-founder / Advisory Board

Stefan is a biochemist and computational biologist with a strong background in deep learning and data analysis.

Prof. Dr. Stefan Bonn
Prof. Dr. Stefan BonnCo-founder / Advisory Board

Dr. Herbert Stadler

Co-founder / Advisory Board

Herbert is a neuroscientist and successful biotech entrepreneur.

Dr. Herbert Stadler
Dr. Herbert StadlerCo-founder / Advisory Board

Title: DMRT5, DMRT3, and EMX2 Cooperatively Repress Gsx2 at the Pallium-Subpallium Boundary to Maintain Cortical Identity in Dorsal Telencephalic Progenitors
Authors: Desmaris E, Keruzore M, Saulnier A, Ratié L, Assimacopoulos S, De Clercq S, Nan X, Roychoudhury K, Qin S, Kricha S, Chevalier C, Lingner T, Henningfeld KA, Zarkower D, Mallamaci A, Theil T, Campbell K, Pieler T, Li M, Grove EA, Bellefroid EJ.
DOI: https://doi.org/10.1523/jneurosci.0375-18.2018
File: (PDF)

Title: Retinoic acid-induced expression of Hnf1b and Fzd4 is required for pancreas development in Xenopus laevis.
Authors: Gere-Becker MB, Pommerenke C, Lingner T, Pieler T.
DOI: https://doi.org/10.1242/dev.161372
File: (PDF)

Title: Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8 + T Cells
Authors: Nicolas Page, Bogna Klimek, Mathias De Roo, Karin Steinbach, Hadrien Soldati, Sylvain Lemeille, Ingrid Wagner, Mario Kreutzfeldt, Giovanni Di Liberto, Ilena Vincenti, Thomas Lingner, Gabriela Salinas, Wolfgang Brück, Mikael Simons, Rabih Murr, Jonathan Kaye, Dietmar Zehn, Daniel D Pinschewer, Doron Merkler
DOI: https://doi.org/10.1016/j.immuni.2019.02.011
File: (None)

Title: Oasis 2: improved online analysis of small RNA-seq data.
Authors: Rahman RU, Gautam A, Bethune J, Sattar A, Fiosins M, Magruder DS, Capece V, Shomroni O, Bonn S.
DOI: https://doi.org/10.1186/s12859-018-2047-z
File: (PDF)

Title: The landscape of human mutually exclusive splicing.
Authors: Hatje K, Rahman RU, Vidal RO, Simm D, Hammesfahr B, Bansal V, Rajput A, Mickael ME, Sun T, Bonn S, Kollmar M.
DOI: https://doi.org/10.15252/msb.20177728
File: (PDF)